Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

FDA Drug Recalls

6,161 recalls · Class II, newest first

Class II · Moderate risk

Testosterone USP 99.5%

Lack of Assurance of Sterility: The firm is recalling all sterile preparations within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination Qualgen NDC 69761-125-01 D-0387-2016
Class II · Moderate risk

Estradiol USP 99.5%

Lack of Assurance of Sterility: The firm is recalling all sterile preparations within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination Qualgen NDC 69761-006-01 D-0386-2016
Class II · Moderate risk

PGE 25mcg/ml

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Terminated Sterility / contamination Pacific Healthcare, Inc dba B&B Pharmacy D-0180-2016
Class II · Moderate risk

Papa/Pge1/Phento

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Terminated Sterility / contamination Pacific Healthcare, Inc dba B&B Pharmacy D-0179-2016

Recalls by year